KENNEDY CAPITAL MANAGEMENT LLC - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 70 filers reported holding CARDIFF ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q1 2022$419,000
-59.1%
168,902
-0.9%
0.01%
-54.5%
Q4 2021$1,024,000
-12.6%
170,447
-3.1%
0.02%
-15.4%
Q3 2021$1,171,000
-33.6%
175,827
-33.7%
0.03%
-31.6%
Q2 2021$1,763,000
-29.1%
265,128
-1.2%
0.04%
-24.0%
Q1 2021$2,485,000
-12.3%
268,373
+70.4%
0.05%
-21.9%
Q4 2020$2,834,000157,5350.06%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
CAXTON CORP 2,522,083$15,158,00012.39%
Octagon Capital Advisors LP 982,753$5,906,0001.15%
Altium Capital Management LP 337,000$2,025,0000.56%
ACT CAPITAL MANAGEMENT, LLC 102,500$616,0000.44%
Eventide Asset Management 1,670,399$10,039,0000.13%
Artal Group S.A. 750,000$4,508,0000.12%
Aquatic Capital Management LLC 8,000$48,0000.09%
ELKHORN PARTNERS LIMITED PARTNERSHIP 17,300$104,0000.06%
Anson Funds Management LP 69,381$417,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 170,447$1,024,0000.02%
View complete list of CARDIFF ONCOLOGY INC shareholders